1-8 of 8
Marianke L.J. van Schie
Close
Sort by
Journal Articles

HLA Class II Disparity Is Necessary and Sufficient for Induction of Effective Anti-Tumor Immunity by Donor Lymphocyte Infusion in a NOD/Scid Mouse Model for Human Acute Lymphoblastic Leukemia

Sanja Stevanovic, MSc, Marianke L.J. van Schie, Marieke Griffioen, PhD, J.H. Frederik Falkenburg, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 648.
https://doi.org/10.1182/blood.V118.21.648.648
Published: 2011
Journal Articles

Rituximab and Alemtuzumab in Combination, but Not Alone, Induce Complete Remissions in a Preclinical Animal Model of Primary Human ALL: Rationale for Combination Treatment.

Bart Nijmeijer, PhD, Marianke L.J. van Schie, Roel Willemze, PhD, J.H. Frederik Falkenburg, PhD
Journal: Blood
Blood (2007) 110 (11): 2833.
https://doi.org/10.1182/blood.V110.11.2833.2833
Published: 2007
Journal Articles

Establishment and Characterization of a tel/abl Rearrangement Responsible for Imatinib Sensitivity in bcr/abl Negative Acute Lymphoblastic Leukemia.

Jörg Bäumler, PhD, J.H. Frederik Falkenburg, PhD, Marianke L.J. van Schie, Karoly Szuhai, PhD, Martine Pape, Sina Droll, Oliver G. Ottmann, PhD, Bart Nijmeijer, PhD
Journal: Blood
Blood (2007) 110 (11): 4280.
https://doi.org/10.1182/blood.V110.11.4280.4280
Published: 2007
Journal Articles

Upregulation of CD20 on Human Acute Lymphoblastic Leukemia Cells by IL-4 and CpG Motif Containing Oligonucleotides Increases Susceptibility to Rituximab.

Bart Nijmeijer, Marianke L.J. Van Schie, Roelof Willemze, J.H. Frederik Falkenburg
Journal: Blood
Blood (2006) 108 (11): 1879.
https://doi.org/10.1182/blood.V108.11.1879.1879
Published: 2006
Journal Articles

The Prodrug AQ4N Displays Potent Anti-Tumor Activity in a Xenotransplantation Model of Primary Human Acute Lymphoblastic Leukemia.

Bart A. Nijmeijer, Marianke L.J. Van Schie, Susan E. Alters, Alvin Wong, Jeffrey L. Cleland, Roelof Willemze, J.H. Frederik Falkenburg
Journal: Blood
Blood (2005) 106 (11): 1837.
https://doi.org/10.1182/blood.V106.11.1837.1837
Published: 2005
Journal Articles

In Vitro Cell Division Analysis Reveals High Proliferative Potential and Clonogenicity within Primary Common-Type Human Acute Lymphoblastic Leukemia.

Bart A. Nijmeijer, Marianke L.J. Van Schie, Roelof Willemze, J.H. Frederik Falkenburg
Journal: Blood
Blood (2005) 106 (11): 857.
https://doi.org/10.1182/blood.V106.11.857.857
Published: 2005
Journal Articles

Toxicity and Effectivity of the Experimental Cytotoxic Drug Cyclopentenyl Cytosine in NOD/scid Mice with Acute Lymphoblastic Leukemia (ALL).

Kirsten J.M. Schimmel, PharmD, Bart A. Nijmeijer, PhD, Marianke L.J. van Schie, J.H. Frederik Falkenburg, PhD, Henk-Jan Guchelaar, PhD
Journal: Blood
Blood (2005) 106 (11): 4574.
https://doi.org/10.1182/blood.V106.11.4574.4574
Published: 2005
Journal Articles

Expansion and Transformation of Primary Acute Lymphoblastic Leukemia Cells into Antigen-Presenting Cells using a Novel Culturing System Enables the Generation of Leukemia-Reactive T Cell Responses that Are Effective in Vivo.

Bart A. Nijmeijer, Marianke L.J. Van Schie, Roel Willemze, J.H. Frederik Falkenburg
Journal: Blood
Blood (2004) 104 (11): 303.
https://doi.org/10.1182/blood.V104.11.303.303
Published: 2004